FOXP3 and type 1 diabetes mellitus: This is based on the observation that defects in Treg function have been reported in autoimmune diseases including T1D and MS [21, 22] and that experimental deletion of FOXP3 or reduced Treg function results in autoimmune disease in many model systems [23, 24].